The PE Ratio as of November 2024 (TTM) for SeaStar Medical Holding Corporation (ICU) is -0.16

According to SeaStar Medical Holding Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -0.16. This represents a change of -83.77% compared to the average of -0.99 of the last 4 quarters.

SeaStar Medical Holding Corporation (ICU) Historical PE Ratio (quarterly & annually)

How has ICU PE Ratio performed in the past?

The mean historical PE Ratio of SeaStar Medical Holding Corporation over the last ten years is -8.36. The current -0.16 PE Ratio has changed 91.38% with respect to the historical average. Over the past ten years (40 quarters), ICU's PE Ratio was at its highest in in the December 2021 quarter at 156.91. The PE Ratio was at its lowest in in the June 2022 quarter at -20.35.

SeaStar Medical Holding Corporation (ICU) PE Ratio by Quarter and Year

Discovering the peaks and valleys of SeaStar Medical Holding Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

SeaStar Medical Holding Corporation (ICU) Average PE Ratio

How has ICU PE Ratio performed in the past?

The current PE Ratio of SeaStar Medical Holding Corporation (ICU) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

SeaStar Medical Holding Corporation (ICU) PE Ratio vs. Peers

How is ICU’s PE Ratio compared to its peers?

SeaStar Medical Holding Corporation’s PE Ratio is greater than Virios Therapeutics, Inc. (-0.76), less than ZyVersa Therapeutics, Inc. (-0.07), greater than Sonnet BioTherapeutics Holdings, Inc. (-2.73), less than Revelation Biosciences, Inc. (-0.08), greater than Quoin Pharmaceuticals, Ltd. (-0.46), greater than Allarity Therapeutics, Inc. (-1.62), less than Kiromic BioPharma, Inc. (-0.08), greater than Virax Biolabs Group Limited (-0.68), greater than Biodexa Pharmaceuticals Plc (-0.22), greater than Palisade Bio, Inc. (-0.24), greater than Unicycive Therapeutics, Inc. (-0.65), greater than Apexigen, Inc. (-0.36), greater than Immix Biopharma, Inc. (-2.41), less than CNS Pharmaceuticals, Inc. (-0.00), less than eFFECTOR Therapeutics, Inc. (-0.00), less than Navidea Biopharmaceuticals, Inc. (0.03),

Build a custom stock screener for SeaStar Medical Holding Corporation (ICU) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SeaStar Medical Holding Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SeaStar Medical Holding Corporation (ICU) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SeaStar Medical Holding Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.